Skip to NavigationSkip to content

Boehringer Ingelheim open new plant in Catalonia

Published on 17/06/19 at 11:27am

Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallès near Barcelona.

The new plant will manufacture Boehringer Ingelheim’s COPD and asthma drug Respimat.

The Catalonia facility has seen Boheringer invest €120 million into the new plant which will see the creation of up to 200 new jobs.

Peter Ploeger, Managing Director of Boehringer Ingelheim Spain, commented: “This new plant is a recognition of the excellence and professionalism of hundreds of workers who, through their dedication, efforts, and commitment, have positioned the Boehringer Ingelheim facilities in Sant Cugat as one of the Group’s European innovation hubs, and a global leader due to its excellence, quality and environmental standards.”

The 17,000 sqm facility will include production areas, laboratories, technical areas, warehouses and an office.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches